Why Did the FDA Crush These 3 Biotech Companies?

Why Did the FDA Crush These 3 Biotech Companies?

Although investors were not satisfied with the FDA approval, Iclusig was at least a viable source of revenue for the company. Last quarter, Iclusig sales generated $14 million in revenue, a big jump from the revenue of $0.32 million it reported in the

2
Like
Save

Comments

Write a comment

*